Desmopressin ODT Shows Favorable Long-Term Safety in Men With Nocturia: Japan Surveillance Study Written By Medha Baranwal5 April 2026 8:30 PM ISTJapan: A large post-marketing surveillance study in Japan has provided important real-world insights into the long-term safety of desmopressin orally...
GLP-1 Receptor Agonists Reduce Cardiovascular Risk Among Atopic Dermatitis Patients, Suggests Study Written By Medha Baranwal5 April 2026 8:15 PM ISTUSA: Researchers have found in a new study that patients with atopic dermatitis who used GLP-1 receptor agonists showed a lower long-term risk of...
Postprandial Glucose Dip Linked to Increased Hunger, Suggests Study Written By Aashi verma4 April 2026 11:00 AM ISTResearchers have found in a new study that among adults without diabetes, postprandial glucose dip (PGD) was associated with greater perceived hunger...
Rising Use of GLP-1 Receptor Agonists in Youth With Type 2 Diabetes: Study Written By Jacinthlyn Sylvia4 April 2026 8:00 AM ISTA study published in Pediatrics journal revealed that the use of GLP-1 receptor agonists (GLP-1 RAs) in youth aged 10-17 years with type 2 diabetes...
Statins Show Promise in Wound Healing, Reveals Research Written By Medha Baranwal3 April 2026 8:15 PM ISTUSA: Researchers have found in a new study that statins may have therapeutic potential in wound care. However, further research is needed to...
Sitagliptin/Empagliflozin FDC Improves Glycaemic Control with Good Safety: Study Written By Dr. Shravani Dali3 April 2026 9:30 AM ISTResearchers have found in a new study that fixed-dose combination of sitagliptin and empagliflozin significantly improved glycaemic control at 24...
Elevated Lp(a) and Diabetes Synergistically Increase Mortality Risk in CAD, reports research Written By Dr. Shravani Dali3 April 2026 9:00 AM ISTResearchers have found in a new study that among patients with coronary artery disease (CAD), elevated lipoprotein(a) [Lp(a)] and diabetes mellitus...
FDA Approves Orforglipron as Second Oral GLP-1 Agonist for Weight Loss Written By Dr. Kamal Kant Kohli2 April 2026 11:00 AM ISTThe FDA has approved Orforglipron as the second oral GLP-1 receptor agonist for weight management in adults with obesity or overweight with...
Quadruple Therapy More Effective Than Metformin Dose Escalation in Diabetes, Suggests Study Written By Medha Baranwal2 April 2026 9:30 AM ISTSouth Korea: Researchers have found in a new study from South Korea that adding a fourth oral antidiabetic drug to an existing triple therapy achieved...
Evolocumab can prevent first heart attack or stroke in high-risk patients with diabetes, suggests study Written By Dr. Kamal Kant Kohli2 April 2026 8:30 AM ISTMass General Brigham researchers found that the intensive cholesterol-lowering therapy evolocumab reduced the risk of a first major cardiovascular...
BMI Variability Independent Predictor of DKD Progression in Type 1 Diabetes, Finds Study Written By Medha Baranwal1 April 2026 9:30 AM ISTUK: New research has revealed that fluctuations in body mass index (BMI) may independently predict the progression of diabetic kidney disease (DKD) in...
Once-Daily Prednisolone Shows Metabolic Advantages Over Standard Hydrocortisone in Adrenal Insufficiency: JAMA Written By Jacinthlyn Sylvia31 March 2026 8:30 PM ISTA recent clinical trial published in the Journal of the American Medical Association found once-daily low-dose prednisolone as a safe alternative to...
